India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have ...

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

TME Pharma Provides Results of Final Exercise of Warrants Z 1,948 Warrants Z were exercised resulting in the issuance of 2,435 new ordinary shares Regulatory News: TME Pharma N.V. (Euronext Growth ...

As North America CEO, Richard will advance Sun Pharma's diverse portfolio of innovative medicines, generics and over-the-counter products in both the U.S. and Canada. With a background spanning ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

Lawmakers bet millions on pharma stocks as Trump targets industry Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

The impact of pharmaceutical roundtripping on the trade balance is both too big to continue and too big to ignore. Time for some real changes.

In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management.

In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management.

TME Pharma and SERI have already filed patent applications covering use of NOX-E36 in glaucoma filtration surgery and other ophthalmic diseases 1 and will continue working together to secure joint IP ...